Skip to Content

T29 (Carbamazepine Extended-Release 400 mg)

Pill with imprint T29 is White, Capsule-shape and has been identified as Carbamazepine Extended-Release 400 mg. It is supplied by Taro Pharmaceutical Industries Ltd..

Carbamazepine is used in the treatment of trigeminal neuralgia; epilepsy; schizoaffective disorder; bipolar disorder; borderline personality disorder (and more), and belongs to the drug class dibenzazepine anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Carbamazepine 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for T29

Carbamazepine extended-release 400 mg T29
Carbamazepine extended-release 400 mg T29  Front
Carbamazepine extended-release 400 mg T29  Back
Carbamazepine extended-release 400 mg T29

Carbamazepine Extended-Release

400 mg
Prescription only
Drug Class:
Dibenzazepine anticonvulsants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Taro Pharmaceutical Industries Ltd.
Inactive Ingredients:
corn starch
diethyl phthalate
lactose monohydrate
magnesium stearate
microcrystalline cellulose
sodium starch glycolate type A potato
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
54868-6074 Physicians Total Care Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.